Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
International Journal of Stroke (IJS) recently shared a post on X:
”Just Accepted!
Study finds hemorrhagic transformation was associated with onset-to-imaging time and presence of severe hypoperfusion. No interaction found between time and severe hypoperfusion.”
Read the full article here.
A new study is reinforcing the importance of timely management of stroke in an article ‘Association between Time and Severe Hypoperfusion with Risk of Hemorrhagic Transformation in Stroke Patients’ by Umberto Pensato et al., published in International Journal of Stroke (IJS).
Emerging evidence highlights that both severe hypoperfusion and time spent in a hypoperfused state contribute to the risk of parenchymal hematoma (PH) in ischemic stroke.
A recent analysis confirms that while each factor independently increases the likelihood of hemorrhagic transformation (HT), their interaction was not statistically significant.
These findings suggest that the risk of HT is influenced by distinct pathways related to hypoperfusion severity and duration.
Identifying patients with a “leaky core”—those with severely compromised blood-brain barriers—could enhance patient selection for targeted interventions!
Hemostasis Today, your daily update on scientific advancements in the World of Stroke.
-
Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
-
Oct 30, 2025, 07:56Vallabh Janardhan: Strokes Affecting Younger Patients
-
Oct 30, 2025, 07:55“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
-
Oct 30, 2025, 07:42Carmelo Gurnari Leads Leukemia Research at Cleveland Clinic and Champions Care Grounded in Partnership
-
Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
-
Oct 30, 2025, 07:52Haemophilia B - An illustrative review of current challenges and opportunities
-
Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
-
Oct 29, 2025, 07:39Pablo Corral: Pushing the Limits of LDLc: Emerging Paradigms in CV Risk Reduction
-
Oct 29, 2025, 07:38Thijs van Haaps and Team Show That Andexanet Alfa May Go Beyond Apixaban and Rivaroxaban
-
Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Oct 30, 2025, 11:56Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
-
Oct 30, 2025, 07:40Dr Gee Teak Sheng: Visibility is Safety — and in UBE Spine Surgery, That Clarity Begins with Hemostasis
-
Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
-
Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
-
Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague